Drawing for STRAGEN

USPTO serial 79121314

STRAGEN

Reviewed by CopyMark Law Group

Reg. 4449450Status 709
Filing date
Status date
Registration date
Dec 17, 2013
Examiner
LOBO, DEBORAH E
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with STRAGEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemical preparations for industrial and scientific use, including for diagnostic use; chemical reagents other than for medical or veterinary use; diagnostic preparations, other than for medical or veterinary use; chemical substances, namely, reagents for chemical analysis in laboratoriesSECTION 71 - CANCELLED
005Pharmaceutical preparations and substances, namely, antibiotics, anticonvulsants, antiepileptic preparations and substances for the treatment of cardiological diseases, bone diseases, oncology, gynecology, rhumatology, phlebology and dermatological disorders and diseases; chemical reagents for medical and veterinary use; diagnostic preparations for medical and veterinary useSECTION 71 - CANCELLED
035Administrative processing of applications for marketing release authorization and regulatory approval of pharmaceutical and medical products; electronic data collection and data submission services for commercial purposes provided in connection with clinical research, testing, trials and finalization of pharmaceutical products, medical devices and biotechnologySECTION 71 - CANCELLED
042Consulting in the field of pharmaceutical science; research, design and development in the medical and pharmaceutical field; development of medicines for others; conducting clinical and preclinical trials and supervision of clinical and preclinical trials; development of medicines in compliance with regulatory requirements; conducting clinical trials for others in the field of medicine compatibility; pharmacovigilance services for others, namely, monitoring the quality and efficacy of pharmaceutical preparations; consultancy in the field of medical and pharmaceutical research; providing advice in connection with clinical trial research, testing and evaluation of pharmaceutical products, medical devices and biotechnology; evaluating medicines of others to assure compliance with regulatory requirements; providing data analysis of data obtained in connection with clinical trial research and testing of pharmaceutical products, medical devices and biotechnology; scientific research relating to the evaluation of new medicines; development of pharmaceutical preparations, remedies and medicines; technological services, namely, scientific research, analysis and testing in the pharmaceutical and health care sector; scientific research and analysis, namely, conducting early evaluations in the field of new pharmaceutical preparations; scientific research and development in the pharmaceutical field; scientific research and development, namely, conducting clinical trials of medicines of others; product development in the field of medicineSECTION 71 - CANCELLED
044Consultancy in the field of medical treatments and advice in the pharmaceutical fieldSECTION 71 - CANCELLED
045Regulatory compliance consultancy in the field of pharmaceutical products, medical devices and biotechnology productsSECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 7, 2023CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Apr 11, 2023CRCVCORRECTION TRANSACTION RECEIVED FROM IB
Apr 5, 2023FINPFINAL DECISION TRANSACTION PROCESSED BY IB
Jan 11, 2023XXSSGENERIC MADRID TRANSACTION SENT TO IB
Jan 11, 2023INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Jan 11, 2023XXCRGENERIC MADRID TRANSACTION CREATED
Nov 1, 2022RNWLINTERNATIONAL REGISTRATION RENEWED
Oct 26, 2021INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 26, 2021C71TCANCELLED SECTION 71
May 8, 2020FINVFINAL DECISION TRANSACTION PROCESSED BY IB
Mar 15, 2018NREPNEW REPRESENTATIVE AT IB RECEIVED
Jun 13, 2014FINOFINAL DECISION TRANSACTION PROCESSED BY IB
May 9, 2014FICSFINAL DISPOSITION NOTICE SENT TO IB
May 9, 2014FIMPFINAL DISPOSITION PROCESSED
Mar 17, 2014FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 17, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 1, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 30, 2013GPNXNOTIFICATION PROCESSED BY IB
Sep 11, 2013OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 11, 2013OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 11, 2013NPUBNOTICE OF PUBLICATION
Aug 27, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 27, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 26, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 26, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 16, 2013ALIEASSIGNED TO LIE
Aug 14, 2013NREVNOTICE OF REVIVAL - MAILED
Aug 14, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 14, 2013PETGPETITION TO REVIVE-GRANTED
Aug 14, 2013PROATEAS PETITION TO REVIVE RECEIVED
May 10, 2013ATRVATTORNEY REVIEW COMPLETED
May 10, 2013LIMSLIMITATION OF GOODS/SERVICES FROM IB ENTERED
Apr 20, 2013LIMGLIMITATION OF GOODS RECEIVED FROM IB
Feb 27, 2013RFNTREFUSAL PROCESSED BY IB
Feb 5, 2013RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 5, 2013RFRRREFUSAL PROCESSED BY MPU
Feb 5, 2013RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 4, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 4, 2013DOCKASSIGNED TO EXAMINER
Dec 18, 2012MAFRAPPLICATION FILING RECEIPT MAILED
Dec 12, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 7, 2012REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance